These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 13728415)

  • 1. Heparin clearing and inhibition in ischaemic heart disease.
    NESTEL PJ; MASHFORD ML
    Clin Sci; 1961 Feb; 20():41-8. PubMed ID: 13728415
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of sublingual heparin on lipemia clearing and on recurrence of myocardial infarction.
    FULLER HL
    Angiology; 1960 Jun; 11():200-6. PubMed ID: 13825618
    [No Abstract]   [Full Text] [Related]  

  • 3. [Observations on "clearing" heparin treatment in patients with coronary insufficiency].
    TARTARA D; CARUZZO C; PAGANO PG; PELLEGRINI A; ANGELINO PF
    Minerva Med; 1962 Mar; 53():736-9. PubMed ID: 13919715
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive heparin therapy in coronary heart disease.
    MAY LM
    Tex State J Med; 1961 Aug; 57():690-5. PubMed ID: 13768529
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on heparin and lipemia clearing factor; inhibition towards clearing in plasma from normal and atherosclerotic individuals.
    ANGERVALL G; HOOD B
    Acta Med Scand; 1957 Jun; 157(5):407-15. PubMed ID: 13434786
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the clearing action of a heparin-trypsin compound].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1962 Jan; 38():1-2. PubMed ID: 13875919
    [No Abstract]   [Full Text] [Related]  

  • 7. The clearing by heparin of alimentary lipaemia in coronary artery disease.
    OLIVER MF; BOYD GS
    Clin Sci; 1953; 12(3):293-8. PubMed ID: 13082751
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the long-term heparin treatment of arteriosclerosis and esential hyperlipemia].
    HEYMANN W
    Internist (Berl); 1961 Mar; 2():140-54. PubMed ID: 13714075
    [No Abstract]   [Full Text] [Related]  

  • 9. [Heparin in the pathogenesis, prevention and therapy of ischemic heart disease].
    Riecanský I; Kusá O; Luknárová O; Haviar V
    Vnitr Lek; 1983 May; 29(5):439-45. PubMed ID: 6880060
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of multiple injections of heparin on the hyperlipemia of atherosclerosis. Preliminary report.
    WOLDOW A; LOPEZ RH; GOLDBERG H
    J Albert Einstein Med Cent (Phila); 1962 Apr; 10():68-72. PubMed ID: 14007910
    [No Abstract]   [Full Text] [Related]  

  • 11. [Heparin clearing test in atherosclerotics].
    LEMAIRE A; LOEPER J; CLOAREC M; COTTET J
    Presse Med (1893); 1963 Feb; 71():325-6. PubMed ID: 13929524
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased prevalence of coronary heart disease and ischaemic stroke in the Asia-Pacific region.
    Ramaraj R
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):115-6. PubMed ID: 19238001
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanism of the clearing action of heparin].
    KRAUPP O
    Wien Klin Wochenschr; 1956 Nov; 68(48):937-41. PubMed ID: 13401735
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthetic heparinoids and thrombotic vascular diseases. (Apropos of 60 cases)].
    DULAC JF; DOURY P; BEN-ZENOU A; WEIL B
    Sem Hop; 1962 Mar; 38():1064-8. PubMed ID: 13888337
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of novocaine on the blood lipids of patients with coronary atherosclerosis].
    IAKOVLEVA IN
    Sov Med; 1960 Nov; 25():47-52. PubMed ID: 13717231
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo studies of the role of albumin in endogenous and heparin-activated lipemia-clearing in nephrotic rats.
    ROSENMAN RH; FRIEDMAN M
    J Clin Invest; 1957 May; 36(5):700-5. PubMed ID: 13428860
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of MER-29 on the clinical picture, electrocardiogram and blood lipids in patients with coronary insufficiency].
    de OLIVEIRA J; PRACA MA
    Hospital (Rio J); 1961 Mar; 59():545-52. PubMed ID: 13730773
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of heparin in the treatment of coronary diseases; heparin in coronary diseases except infarct].
    CAMERON-CURRY V
    Minerva Med; 1957 Jan; 48(6):183-7. PubMed ID: 13418464
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of heparin as a clearing agent in acute and chronic coronary insufficiency].
    CARUZZO C; PELLEGRINI A; PAGANO PG; TARTARA D; ANGELINO PF
    Atti Soc Ital Cardiol; 1962; 22(2)():Comunicazioni 79-80. PubMed ID: 14018997
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heparinized rat blood inducing clearing & lipolysis phenomena in lipemic plasma].
    LE BRETON E; FRAYSSINET C; MAY P
    Bull Schweiz Akad Med Wiss; 1957 Apr; 13(1-4):229-38. PubMed ID: 13436970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.